Insider Transactions in Q3 2018 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q3 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2018
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
741
-0.5%
|
$41,496
$56.67 P/Share
|
|
Aug 02
2018
|
Tony W Ho Executive VP, Head of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
14,631
-39.02%
|
$702,288
$48.43 P/Share
|
|
Aug 01
2018
|
Tony W Ho Executive VP, Head of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+50.0%
|
-
|
|
Jul 05
2018
|
Pablo J Cagnoni Director |
SELL
Open market or private sale
|
Direct |
1,684
-100.0%
|
$104,408
$62.0 P/Share
|
|
Jul 05
2018
|
Pablo J Cagnoni Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,684
+50.0%
|
$8,420
$5.59 P/Share
|
|
Jul 03
2018
|
Pablo J Cagnoni Director |
SELL
Open market or private sale
|
Direct |
5,816
-100.0%
|
$360,592
$62.0 P/Share
|
|
Jul 03
2018
|
Pablo J Cagnoni Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,816
+50.0%
|
$29,080
$5.59 P/Share
|